Daratumumab, Elotuzumab, and the Development of Therapeutic Monoclonal Antibodies in Multiple Myeloma

Laubach, JP; Prada, CEP; Richardson, PG; Longo, DL

Laubach, JP (reprint author), Dana Farber Canc Inst, Boston, MA 02115 USA.

CLINICAL PHARMACOLOGY & THERAPEUTICS, 2017; 101 (1): 81

Abstract

There has been substantial progress in clinical outcomes for patients withmultiple myeloma (MM). This encouraging trend derives in large part from the......

Full Text Link